Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models

PLoS ONE - United States
doi 10.1371/journal.pone.0046613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Targeted Delivery of Doxorubicin to HER2 Positive Tumor Models

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Ovarian Cancer Stem Cells Express ROR1, Which Can Be Targeted for Anti–cancer-Stem-Cell Therapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Stem Cell Therapy for Ischemic Stroke Using iPS Cells

Clinical Neurology
Neurology
2013English

Targeted Therapy for Renal Cell Carcinoma

2011English

Dynamics of Leukemia Stem-Like Cell Extinction in Acute Promyelocytic Leukemia

Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy